Cerus Corp. (CERS)
2.72
+0.03
(+1.12%)
USD |
NASDAQ |
Aug 25, 16:00
2.72
0.00 (0.00%)
After-Hours: 05:37
Cerus Enterprise Value : 569.19M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 569.19M |
| August 24, 2026 | 563.15M |
| August 21, 2026 | 587.32M |
| August 20, 2026 | 583.29M |
| August 19, 2026 | 595.38M |
| August 18, 2026 | 577.25M |
| August 17, 2026 | 619.55M |
| August 14, 2026 | 621.57M |
| August 13, 2026 | 593.36M |
| August 12, 2026 | 567.17M |
| August 11, 2026 | 537.96M |
| August 10, 2026 | 528.90M |
| August 07, 2026 | 494.65M |
| August 06, 2026 | 488.61M |
| August 05, 2026 | 478.53M |
| August 04, 2026 | 462.42M |
| August 03, 2026 | 454.36M |
| July 31, 2026 | 454.36M |
| July 30, 2026 | 603.44M |
| July 29, 2026 | 599.41M |
| July 28, 2026 | 609.48M |
| July 27, 2026 | 639.70M |
| July 24, 2026 | 611.50M |
| July 23, 2026 | 599.41M |
| July 22, 2026 | 629.63M |
| Date | Value |
|---|---|
| July 21, 2026 | 649.77M |
| July 20, 2026 | 655.82M |
| July 17, 2026 | 651.79M |
| July 16, 2026 | 667.90M |
| July 15, 2026 | 661.86M |
| July 14, 2026 | 639.70M |
| July 13, 2026 | 643.73M |
| July 10, 2026 | 649.77M |
| July 09, 2026 | 655.82M |
| July 08, 2026 | 653.80M |
| July 07, 2026 | 669.92M |
| July 06, 2026 | 682.00M |
| July 02, 2026 | 657.83M |
| July 01, 2026 | 625.60M |
| June 30, 2026 | 609.48M |
| June 29, 2026 | 616.61M |
| June 26, 2026 | 602.59M |
| June 25, 2026 | 590.57M |
| June 24, 2026 | 546.50M |
| June 23, 2026 | 536.48M |
| June 22, 2026 | 538.49M |
| June 18, 2026 | 558.52M |
| June 17, 2026 | 532.48M |
| June 16, 2026 | 512.45M |
| June 15, 2026 | 522.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DexCom, Inc. | 33.10B |
| Abbott Laboratories | 228.61B |
| AngioDynamics, Inc. | 622.21M |
| Alphatec Holdings, Inc. | 1.933B |
| AtriCure, Inc. | 2.382B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.982M |
| Revenue (Quarterly) | 57.44M |
| Total Expenses (Quarterly) | 60.38M |
| EPS Diluted (Quarterly) | -0.0147 |
| Gross Profit Margin (Quarterly) | 50.61% |
| Profit Margin (Quarterly) | -5.19% |
| Earnings Yield | -1.27% |
| Normalized Earnings Yield | -1.272 |